I The dopamine-induced neurogenic vasodilatation, previously described in the isolated perfused hindleg of the dog, has been studied in anaesthetized dogs with intact circulation in the hindleg. Dopamine was administered intravenously and/or intra-aortically, either as a bolus injection of 4 or 16 JLg/kg, or as a continuous infusion of 4, 8, 16 or 32 gg kg-' min-'. 2 Dopamine, given as a bolus injection or by infusion, reversibly inhibited synaptic transmission in the paravertebral lumbar ganglia, studied with preganglionic stimulation at 1 Hz. The inhibitory effect decreased gradually when the frequency of stimulation was increased to 16 Hz. The inhibition by dopamine was also present when spontaneous postganglionic activity was recorded. These effects were more pronounced on intra-aortic than on intravenous administration of dopamine. 3 In about half of the animals studied, injection or infusion of dopamine elicited a decrease of vascular resistance in the innervated femoral artery, whereas systemic blood pressure either did not change or decreased. In the denervated femoral artery, an increase in vascular resistance was always observed. 4 The decrease in femoral vascular resistance was considered to correspond with neurogenic vasodilatation caused by paravertebral ganglionic inhibition since (i) it only occurred in the innervated hindleg, (ii) blood pressure did not rise, (iii) this decrease was insensitive to atropine or propranolol and (iv) it was blocked by small doses of haloperidol. When hypovolemic shock was produced, the incidence of the neurogenic decrease of vascular resistance was smaller. S Dopamine also increased renal blood flow. This increase was not reduced by the occurrence of the neurogenic vasodilatation in the innervated femoral artery. 6 These results are consistent with the idea that the dopamine-induced neurogenic vasodilatation, originally described in the isolated perfused hindleg of the dog, also occurs when the circulation to the hindleg is intact. This suggests that, in the dog, the inhibitory effect of dopamine on sympathetic ganglia modulates its peripheral vasoconstrictor effects. In hypovolemic shock, where sympathetic nervous activity is high, the inhibitory effect of dopamine on sympathetic ganglia disappears and its direct vasoconstrictor effect on the vessels dominates.
Introduction
In 1963 McDonald & Goldberg reported that a neurogenic vasodilatation occurs in the isolated perfused hindleg of the dog on systemic administration of dopamine. It has been suggested that this phenomenon, which is due to inhibition of sympathetic ganglionic transmission (Bogaert & De Schaepdryver, 1967; Willems, 1973; Willems & Bogaert, 1975a,b) is not involved in the systemic hypotensive effect of dopamine (Eble, 1964; Goldberg, 1972) . It is not even known whether this neurogenic vasodilatation after systemic administration of dopamine takes place in the intact hindleg, as the direct effect of dopamine on the femoral vascular bed is a vasoconstrictor one (McNay, McDonald & Goldberg, 1965) .
We therefore decided to study in detail the effect of intravenous administration of dopamine, as a single 19 injection and by infusion, on the vascular resistance in the intact hindleg and on the ganglionic transmission in the abdominal lateral sympathetic chain of the dog. Dopamine was also given by the intra-aortic route, as earlier experiments were performed in this way (Willems, 1973; Willems & Bogaert, 1975a) .
Preliminary results of this work have been published (Bogaert, Willems & De Schaepdryver, 1975) .
Methods

Ganglionic transmission
Nineteen mongrel dogs of either sex, with body weights ranging between 4 and 8 kg, were used. The animals were anaesthetized with pentobarbitone sodium, in an intravenous dose of 30 mg/kg, further small doses being given as needed. The experimental preparation has been described in detail by Willems (1973) . A bipolar platinum electrode was placed on the cut upper intemodal segment of the fourth or fifth paravertebral ganglion and an electrical stimulus of 0.3 ms duration and supramaximal intensity was applied at a frequency of 1 Hz; in some experiments other frequencies were used, as indicated in the Results section. Postganglionic electrical activity was recorded by a second bipolar platinum electrode on the ramus communicans griseus of the ganglion. Permanent records were made on moving film with a Grass oscilloscope camera for simultaneous evaluation of the time course and the intensity of the effects of the substances studied. The results were measured as the maximal change in amplitude of the evoked spikes.
In 7 of the 19 experiments spontaneous electrical activity was followed on the oscilloscope. Recording from the undivided ramus gave reproducible electrical activity and allowed qualitative evaluation of the effect of dopamine. Bloodflow Twenty-nine mongrel dogs of either sex, with body weights ranging between 12 and 38 kg, were used. They were anaesthetized as described above. 
Drugs
The following drugs, diluted in saline, were used: dopamine hydrochloride (Sigma), (-)-noradrenaline bitartrate (Sigma), (±)isoprenaline hydrochloride (Winthrop), haloperidol (Janssen Pharmaceutica), acetylcholine chloride (Roche), atropine sulphate (Boehringer-Sohn), propranolol hydrochloride (ICI), tetraethylammonium iodide (Merck). The solubilization of haloperidol by the use of lactic acid was described previously (Willems, 1973) . Doses of the drugs are expressed as the base.
Results
Ganglionic transmission
Preganglionic stimulation, I Hz, supramaximal intensity. In 7 dogs dopamine (16 jg/kg) was injected intravenously; it produced an inhibition of the ganglionic transmission of 57.20 + 6.29%. In 4 of these dogs the time course of the inhibition was followed: inhibition was maximal at 17.50±1.04 s after injection. When the same dose of dopamine (16 jg/kg) was injected into the aorta, inhibition was more pronounced, 82.39 ± 4.74% (n= 7; P < 0.05) and occurred earlier, at 8.50 + 0.55 s (n = 4; P < 0.01).
In the same series of dogs, dopamine was infused intravenously (8, 16 and 32 jig kg-' min-') and intraaortically (4, 8, and 16 jig kg-' min7l Bursts of small potentials (10-20 gV) were observed at regular intervals (0.5-2 seconds). They completely disappeared upon injection of tetraethylammonium iodide (10 mg) into the abdominal aorta. In 5 experiments, dopamine was injected as a single dose (16 gg/kg) intravenously or intra-aortically; in all cases a short-lasting inhibition of the spontaneous electrical activity occurred with a time course similar to that observed in the stimulated preparation. No change in systemic blood pressure was observed except in 2 dogs in which intravenous dopamine provoked a blood pressure rise.
In 4 experiments, dopamine (8 and 16,g kg-' min-') was infused intravenously, and in two of them also intra-aortically. Intravenous dopamine produced a decrease of the spike amplitude and spike frequency in 2 dogs; in one dog, blood pressure increased, whereas it decreased in the other. Intra-aortic dopamine decreased both spike amplitude and spike frequency; a blood pressure fall was seen in one dog.
Bloodflow measurements
Denervated femoral artery. Dopamine (4 and 16 jg/kg) was given as a bolus injection intravenously (13 preparations) and intra-aortically (16 preparations) in a series of 17 dogs; all responded with a fall of femoral blood flow; blood pressure either increased, decreased or did not change. In all dogs femoral resistance increased. These results are shown in Table 2 , classified according to the change in systemic blood pressure seen.
(-)-Noradrenaline (0.1 jIg/kg), injected intravenously or intra-aortically in some of these dogs, always caused an increase in systemic blood pressure and a decrease in flow (i.v.: + 8.29 + 1.66 mmHg; -25.11 +8.39%, respectively (n= 7); ao.: + 5.00 + 1.00 mmHg;-62.47 + 2.53% respectively (n=4)). showing a decrease in resistance, an increase in systemic blood pressure (+ 11.33 + 1.49 mmHg; n = 9) occurred. In two dogs both blood pressure and femoral resistance increased. In 5 dogs the same dose of noradrenaline was also injected into the abdominal aorta; femoral resistance rose (+84.29 ± 32.06%) as did systemic blood pressure (+8.00+ 3.10 mmHg).
Propranolol, given in a dose (0.3 mg/kg, i.v.), which blocked the vasodilator effect of isoprenaline (0.1 Igg/kg, i.v.), had no effect on the decrease of femoral resistance elicited by dopamine (i.v. or ao.); it did not influence (-)-noradrenaline-induced reflex vasodilatation (n = 3).
Atropine ( Haloperidol (0.1 mg/kg, iv. or 1 mg, ao.; n= 6) blocked the fall in femoral resistance in the innervated femoral artery by intravenous or intra-aortic dopamine without influencing the (-)-noradrenalineinduced reflex vasodilatation (Figure 3) . Tables 5 and 6 show the response patterns when dopamine was infused (4, 8 and 16 jg kg-' min-', i.v. and/or ao.). In these conditions, we observed a sustained decrease of femoral resistance in some dogs which showed a decrease of systemic blood pressure.
In 3 dogs, intravenous infusion of (-)noradrenaline (0.05 gig kg-' min-') also produced a decrease of femoral resistance (-5.13 +5.13%) but this decrease was accompanied by an increase in systemic blood pressure (+ 7.33 ± 4.37 mmHg). Higher doses (0.1 and 0.2 gg kg-' min-') produced an increase in both femoral resistance and systemic blood pressure. Femoral artery bloodflow and severe blood loss. In 8 dogs, blood was withdrawn from the left femoral artery: in 5 dogs until vascular resistance in the intact right femoral bed increased by 30 to 50% and in 3 dogs bleeding was continued until systemic blood pressure stabilized at a lower level. When dopamine was then infused intravenously (8 jg kg-' min-') only 1 out of the 8 dogs showed a decrease of both femoral resistance (-8.30%) and systemic blood pressure (-4.00 mmHg). In 2 other dogs a decrease in femoral resistance was accompanied by an increase in blood pressure. In 5 dogs both femoral resistance and systemic blood pressure increased. Table 5 Effects of an intravenous infusion of dopamine on systemic blood pressure and on blood flow in the innervated femoral artery of the dog hindleg 4 jg kg-Imin-' (n=20) & Goldberg, 1963; Bogaert & De Schaepdryver, 1967; Willems & Bogaert, 1975a) . The doses and the infusion rates of dopamine, used in the experiments presented here, were chosen because they show the experimentally and clinically interesting effects of dopamine: renal vasodilatation, increase in cardiac contractility, decrease in peripheral resistance, slight or no decline of systemic blood pressure and absence of chronotropic effect (McDonald & Goldberg, 1963; Goldberg, 1972; Ramdohr, Schiiren, Biamino & Schr6der, 1973; Setler, Pendleton & Finlay, 1975) . In many of the dogs, systemic administration of dopamine decreased femoral vascular resistance. However, only those experiments in which a fall in systemic blood pressure accompanies the decrease in femoral resistance, can be used to demonstrate a neurogenic mechanism because of the ganglionic inhibitory effect of dopamine (Willems, 1973 (Gilbert & Goldberg, 1975) . Vasoconstriction also occurs when dopamine is injected directly into the innervated femoral artery (McDonald & Goldberg, 1963; McNay et a!., 1965) . It is only after the administration of a-receptor antagonist drugs that the direct effect of dopamine on the femoral artery is a vasodilatation (McNay & Goldberg, 1966; Higgins, Millard, Braunwald & Vatner, 1973; Bell, Conway, Lang & Padanyi, 1975) .
A fall in vascular resistance, requiring intact innervation of the hindleg, was also observed after the intravenous administration of (-)-noradrenaline, but in this case the fall in resistance was always accompanied by an increase in systemic blood pressure, suggesting that a classical baroreceptorreflex is involved. Intra-aortic administration of (-)-noradrenaline always caused an increase in femoral resistance. We have shown previously that the doses of (-)-noradrenaline and dopamine needed for ganglionic inhibition are the same (Willems, 1973) ; this is also true for the neurogenic vasodilatation (Willems & Bogaert, 1975a) . Such doses of (-)-noradrenaline are too high to be used in these experiments because they always give a pronounced increase in systemic pressure.
Our results confirm our previous reports (Willems, 1973; Willems & Bogaert, 1975a ) that dopamine, Table 6 Effects of an intra-aortic infusion of dopamine on systemic blood pressure and on blood flow in the innervated femoral artery of the dog hindleg. within the dose range used here, inhibits ganglionic transmission in the paravertebral ganglion when injected intra-aortically. Moreover they show that the same effect occurs after intravenous administration. The experiments using sub-maximal preganglionic stimulation, which is closer to the physiological situation than supramaximal stimulation, and the experiments with recording of spontaneous sympathetic activity demonstrate that the same phenomenon probably also occurs in the normally activated ganglion.
The fact that the ganglionic inhibition is less pronounced when a dose of dopamine is injected intravenously than intra-aortically parallels the observation by Bogaert & De Schaepdryver (1967) that for the same dose of dopamine, the neurogenic vasodilatation in the isolated perfused preparation is larger when it is injected intra-aortically. This is also suggested by the fact that in those experiments, in which 4 jg/kg of dopamine decreased both resistance in the innervated hindleg and systemic blood pressure, the effect on the femoral flow is larger when dopamine is injected intra-aortically than intravenously. That the same phenomenon does not occur with 16 gg/kg is probably due to the more pronounced direct vasoconstriction when that dose is given.
Propranolol and atropine, in doses antagonizing fmimetic and muscarinic vasodilatation respectively, did not influence the vasodilatation elicited by intravenous dopamine. Haloperidol, which selectively inhibits dopamine-induced ganglionic inhibition (Willems, 1973) and dopamine-induced neurogenic vasodilatation in the isolated perfused hindleg (Willems & Bogaert, 1975a) , blocked the dopamineinduced decrease in femoral resistance without any influence on the reflex dilatation produced by (-)-noradrenaline. The direct vasodilator effect of dopamine in the femoral vascular bed, which is observed after aadrenoceptor blockade, has been attributed to f8-adrenoceptor stimulation (McNay & Goldberg, 1966) but others have found this effect to be resistant to _3-receptor blockade (Higgins et al., 1973) , and antagonized by ergometrine (Bell et al., 1975) . In our experiments, no a-receptor antagonist was given and intra-femoral dopamine elicited only a vasoconstriction. It is therefore unlikely that the fall of resistance which we observed in our experiments and which was found to be resistant to f-blockade but sensitive to haloperidol, can be explained by a direct effect on the femoral vasculature. In our infusion experiments, dopamine also inhibited ganglionic transmission for the duration of the infusion. Therefore in those experiments, in which vascular resistance decreased in the innervated hindleg during a continuous dopamineinfusion without increase in systemic blood pressure, we can assume that a neurogenic vasodilatation, caused by ganglionic inhibition, is present.
In our experiments, a small increase in renal blood flow occurred, which is in agreement with earlier observations (see Goldberg, 1972; Setler et al., 1975) . The neurogenic fall of femoral resistance, which we observed, did not influence the renal vasodilatation, the increase in femoral blood flow being probably too small to decrease renal blood flow.
Only 1 out of 8 dogs with reduced blood volume showed neurogenic vasodilatation with 8 jig kg-' min-' of dopamine, in contrast to 6 out of 25 normal animals. This is perhaps due to the decreasing ability of dopamine to inhibit ganglionic transmission in that situation; this is suggested by our observation that dopamine is in fact less potent as an inhibitor of transmission when stimulus frequency in the ganglionic preparation is increased, thus mimicking increased sympathetic activity in shock (Folkow, 1952) . Very recently it has been suggested (Hall, Schwinghamer & Lalone, 1976 ) that after a rapid haemorrhage the increased vascular resistance in a dog limb is mainly due to circulating catecholamines and not to increased sympathetic tone. This could be an alternative explanation.
Finally we would conclude that, although the neurogenic vasodilatation induced by dopamine is not essential for its hypotensive effect (Eble, 1964; Goldberg, 1972) , it is present in some animals and, as such, could contribute to the systemic effect.
Note added in proof: After completion of this paper, we observed that occasionally dogs respond to local, intrafemoral injection of dopamine in the innervated hindleg with a biphasic response: vasoconstriction followed by vasodilatation, a response similar to that described by Higgins et al. (1973) . This phenomenon is clearly different from the response to intravenous or intra-aortic administration of dopamine described in our paper, i.e. vasodilatation preceding and dominating an occasional vasoconstriction (Figure 2 ).
